26.56500 EUR
0
0%
Last update Dec 9, 3:40 PM CET
Market closed
Day range
26.56500
26.56500
Previous close
26.56500
Open
26.56500
Access this stock data via API
Subscribe
TG Therapeutics, Inc.
26.57
0
0%

Financials

Income statement

Fundamentals currency is USD
Fiscal date 2024
Total reported revenue 280.4M
Cost of revenue 32.8M
Gross profit 247.6M
Operating expense
Research & development 80.4M
Selling general and admin 131.5M
Other operating expenses
Operating income 35.7M
Non operating interest income
Income
Expense 20.5M
Other income expense 6.6M
Pretax income 21.8M
Tax provision 1.9M
Net income 19.9M
Basic EPS 0.2
Diluted EPS 0.2
Basic average shares 123.8M
Diluted average shares 123.8M
EBITDA 42.5M
Net income from continuing op. 19.9M
Minority interests
Preferred stock dividends
Access /income_statement data via our API — starting from the Pro plan.
Market closed

Exchange is currently closed
Pre-market opens in 5 hours 14 minutes

02:45
00:00
09:00
17:30
23:59

Trading Hours (Monday - Friday):

Pre-market
08:00 - 09:00
Main market
09:00 - 17:30
All times are displayed in the Europe/Rome timezone (CET, UTC+01:00).